Totality of the Evidence: Optimizing Dosage Selection Strategies in Oncology

Laura A. Levit

ASCO, Alexandria, VA

Mirat Shah

Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD

Mark J. Ratain

Committee on Clinical Pharmacology and Pharmacogenomics and Center for Personalized Therapeutics, The University of Chicago, Chicago, IL

Elizabeth Garrett-Mayer

ASCO, Alexandria, VA

Atiqur Rahman

US Food and Drug Administration, Silver Spring, MD

Marc Theoret

Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD

R. Donald Harvey

Emory University, Atlanta, GA